Integra LifeSciences Holdings Corporation (IART)

IART Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-516.47	-6.94	67.74	180.55	169.08
Depreciation & Amortization	14.95	140.89	123.51	118.3	119.84
Other Amortization	-	5.59	6.16	6.85	7.03
Loss (Gain) From Sale of Assets	-	1.5	0.78	-7.46	-39.56
Asset Writedown & Restructuring Costs	-	12.21	-	-	2.75
Stock-Based Compensation	-	24.38	20.14	27.73	36.21
Other Operating Activities	551.9	-17.24	3.19	-22.07	-1.08
Change in Accounts Receivable	-	7.4	4.59	-33.91	7.27
Change in Inventory	-	-28.15	-59.77	-29.12	5.37
Change in Accounts Payable	-	-2.67	-20.23	17.34	32.87
Change in Unearned Revenue	-	3.54	0.13	4.27	0.03
Change in Other Net Operating Assets	-	-11.12	-6.29	1.99	-27.38
Operating Cash Flow	50.38	129.38	139.96	264.47	312.43
Operating Cash Flow Growth	-61.06%	-7.56%	-47.08%	-15.35%	53.28%
Capital Expenditures	-	-104.42	-66.87	-42.34	-48.02
Sale of Property, Plant & Equipment	-	-	-	11.15	0
Cash Acquisitions	-	-277.81	-	-51.51	-303.91
Divestitures	-	-	-	23.96	190.47
Sale (Purchase) of Intangibles	-	-9.95	-	-4.74	-0.06
Investment in Securities	-	5.5	-32.69	-	-
Other Investing Activities	-108.06	-4.13	5.38	4.91	0.08
Investing Cash Flow	-108.06	-390.81	-94.18	-58.58	-161.44
Long-Term Debt Issued	-	486.5	165.1	40.75	25.5
Long-Term Debt Repaid	-	-187.13	-110.6	-148.55	-125.5
Net Debt Issued (Repaid)	-	299.37	54.5	-107.8	-100
Issuance of Common Stock	-	6.4	4.32	5.47	6.82
Repurchase of Common Stock	-	-55.98	-280.86	-149.62	-4.8
Other Financing Activities	28.34	-11.92	-7.88	-	-0.25
Financing Cash Flow	28.34	237.86	-229.93	-251.95	-98.23
Foreign Exchange Rate Adjustments	18.02	-6.46	3.89	-10.72	-9.48
Net Cash Flow	-11.33	-30.03	-180.26	-56.79	43.28
Free Cash Flow	50.38	24.96	73.09	222.13	264.41
Free Cash Flow Growth	101.83%	-65.84%	-67.09%	-15.99%	60.30%
Free Cash Flow Margin	3.08%	1.55%	4.74%	14.26%	17.14%
Free Cash Flow Per Share	0.66	0.32	0.91	2.66	3.09
Cash Interest Paid	-	64.4	44.3	42.2	43.2
Cash Income Tax Paid	-	22.7	23.6	35.9	49.5
Levered Free Cash Flow	-	90.15	177.71	165.64	377.4
Unlevered Free Cash Flow	-	128.7	203.65	189.79	401.87
Change in Working Capital	-	-31.01	-81.57	-39.42	18.16

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q